Mitchell McLeod Pugh & Williams’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,672
Closed -$1.39M 157
2015
Q1
$1.39M Buy
4,672
+20
+0.4% +$5.7K 1.27% 18
2014
Q4
$1.2M Buy
+4,652
New +$1.16M 1.11% 22

Other funds holding AGN

Mitchell McLeod Pugh & Williams's AGN Position: Q2 2015 in Review

Mitchell McLeod Pugh & Williams sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 4,672 shares — an estimated $1.39M sold.

Mitchell McLeod Pugh & Williams first reported a position in AGN in Q4 2014 and held it in 2 quarters. The position peaked at $1.39M in Q1 2015. 1,036 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Mitchell McLeod Pugh & Williams reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Mitchell McLeod Pugh & Williams sold 4,672 Allergan plc shares in Q2 2015, an estimated $1.39M.
  • Mitchell McLeod Pugh & Williams first reported a position in Allergan plc in Q4 2014 and held it in 2 quarters.
  • Mitchell McLeod Pugh & Williams's Allergan plc position peaked at $1.39M in Q1 2015.
  • 1,036 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2015, filed 20 Jul 2015.